http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110101676-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11d18be396970ff40fd4b0d214c8dc5b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
filingDate 2019-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_829d9e744caad9ee90738a31aa0f86d9
publicationDate 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110101676-A
titleOfInvention Preparation method of pharmaceutical intermediate pyrrolidone compounds
abstract The present invention provides a method for preparing a pharmaceutical intermediate pyrrolidone compound, comprising the following steps: S1: preparing a preparation material, wherein the preparation material comprises the following 3.5-18.5 parts by weight of raw material zopiclone, 9 parts by weight of hydroxyethyl cellulose -15 parts, 55-78 parts of microcrystalline cellulose, 5-15 parts of low-substituted hydroxypropyl cellulose, 0.5-2.5 parts of sweetener, 0.5-1 part of lubricant, 0.5-1 part of glidant; S2: the The main drug zopiclone is suspended in an aqueous solution of hydroxyethyl cellulose, and then spray-dried to form pretreated main drug granules; S3: The pretreated main drug granules and microcrystalline cellulose, low-substituted hydroxypropyl cellulose, sweet taste It is prepared by sieving and tableting after mixing the agent, lubricant and glidant. The invention can quickly disintegrate in a short time, is convenient to take, effectively improves the drug efficacy (bioavailability) of the tablet, and plays a role quickly.
priorityDate 2019-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453635562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448540569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424599094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420637070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152753444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9261

Total number of triples: 40.